Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

CD2AP (CD2 associated protein)

Written2017-11Simona Panni
DiBEST Department (Biologia, Ecologia, Scienze della Terra), via Pietro Bucci, Cubo 6C 87036 Arcavacata di Rende, CS (Italy). simona.panni@unical.it

Abstract CD2AP gene encodes for an adaptor protein with high homology to Cin85. It was originally cloned as CD2 interacting protein and, in an independent study, as p130-Cas interacting protein. It contains three SH3 domains, a proline-rich motif and a coiled-coil domain that allow it to form complexes with numerous proteins and to participate in different physiological processes. Several evidences suggest that it links cell surface proteins and specialized junctions with the actin cytoskeleton and that it regulates the assembly of actin filaments to guide cell shape and movements. Notably, CD2AP plays a crucial role in the glomerular cells differentiation and in the maintenance of the kidney filtration barrier, and CD2AP-deficient mice die of renal failure before the age of six weeks. Mutations resulting in a lower expression of CD2AP were found in FSGS kidney disease patients. It is also involved in neuronal disorders and two single nucleotide polymorphisms of the gene have been associated with increased risk of Alzheimer' s disease. Finally, although the protein is expressed in the majority of the cell types, it was proposed as optimal marker for BPDCN hematological malignancy.

Keywords CD2AP, CD associated protein, CMS, actin binding, cell junction

(Note : for Links provided by Atlas : click)

Identity

Alias_symbol (synonym)CMS
Other aliasMETS1
HGNC (Hugo) CD2AP
LocusID (NCBI) 23607
Atlas_Id 54896
Location 6p12.3  [Link to chromosome band 6p12]
Location_base_pair Starts at 47477789 and ends at 47627260 bp from pter ( according to hg19-Feb_2009)  [Mapping CD2AP.png]
Local_order CD2AP gene is surrounded by LOC105375082 on the 5' end and ADGRF2 on the 3' end (NCBI 2017, Aug 2017). Two pseudogenes (LOC100421517 and RPS12P14) overlap with it.
 
  Chromosomal location of human CD2AP gene, according to NCBI. CD2AP gene is located on Chromosome 6, starting at 47477746 and ending at 47627263. The gene orientation is on the plus strand.
Fusion genes
(updated 2017)
Data from Atlas, Mitelman, Cosmic Fusion, Fusion Cancer, TCGA fusion databases with official HUGO symbols (see references in chromosomal bands)

DNA/RNA

 
  The longest transcript of CD2AP gene. It is 5412 bases long and consists of eighteen exons (represented as vertical bars) divided by 17 introns (represented as lines). Two short non coding regions at 5' and 3' complete the transcript. The length of each exon is reported (in number of bases).
Description The human CD2AP gene is located on chromosome 6p12, it is 149.517 bps long and comprises 18 exons (NCBI Gene ID: 23607, 2017)
Transcription The longest transcript is 5412 bases long, and comprises 18 exons. This transcript codes for the full lenght protein; four short transcripts (less than 700 bases) have been reported, but their functional role is unknown (Ensemble, Aug 2017). Two of these non-coding isoforms retain part of introns.
Pseudogene None

Protein

 
  Schematic representation of the CD2AP protein. Three SH3 domains occupy the amino terminal region of the protein (aa 1-330), followed by a short proline-rich motif (336-422). The carboxyl-terminal region contains an actin capping protein (CP) binding motif and a coiled-coil region (577-638) (Dikic 2002, Bruck et al. 2006).
Description CD2AP protein is an adaptor protein composed of several regions with binding functions: three SH3 domains, one proline rich region, four actin binding domains, AP-2 and CP binding motifs and a coiled-coil region. The protein is 639 aminoacids long and has a predicted molecular weight of 71,451 Dalton. The SH3 domains are located at the amino terminus of the protein and mediate complexes formation. Actually, SH3 domains are short modules of 60 amino acids commonly involved in the assembly and regulation of signalling processes by recognizing polyproline motifs, shaped in a left-handed type II helix, on the surface of the target proteins. In particular, CD2AP SH3 domains selectively recognize polyproline regions containing the consensus PXXXPR. One of this motif is contained in the p53 trascription factor, only in one of the two p53 polymorphic variants P72R, and allows the adaptor protein to selectively bind the 72 R variant (Panni et al. 2015). The crystal structure of two of the SH3 domains of CD2AP have been solved, showing that the domains conserve the typical beta-barrel shape, with five beta strands (Moncalian et al.2006; Yao et al. 2007). Two AP-2 binding motif (FXDXFX) overlap with the first and third SH3 domains respectively, while a third motif lies between the second and the third SH3 (Brett et al. 2002). Beyond these domains, the proline rich region (aa 336-422) contains motifs recognized by the SH3 domains of p130Cas, Src, Fyn, Yes and PI3K, all proteins involved in signal transduction (Kirsch et al. 1999, Dikic 2002). The presence of four putative actin binding sites (aa 534-538; 599-603; 610-614; 631-635) was observed in (Kirsch et al. 1999; Dikic 2002) and the direct binding of CD2AP to actin was shown in (Lehtonen et al. 2002), while the in vivo colocalization and co-immunoprecipitation of CD2AP with actin was demonstrated in (Yuan et al. 2002; Gaidos et al. 2007). Instead a CP (actin barbed-end capping protein) binding motif is present at amino acids 486-502 and mediates the binding of CD2AP to CP (which in turn binds to actin) and the resulting inhibition of the protective function of CP on actin filaments (Bruck et al. 2006; Takeda et al. 2010). The Carboxyl-terminal region adopts a coiled-coil conformation that allows the protein to homodimerise or heterodimerise with the homolog Cin85. (Kirsch et al. 1999, Gaidos et al. 2007)
Expression CD2AP mRNA is ubiquitously expressed in human tissues (Kirsch et al. 1999). In particular, it is strongly expressed in the placenta, colon, kidney, pancreas and thymus, while a lower expression was detected in aorta, skeletal muscle, bladder and uterus (Kirsch et al. 1999).
Localisation CD2AP protein is localised mainly to the plasma membrane and to the cytosol
 
  CD2AP Interaction Network. The network was downloaded from the Intact Database (except for some nodes that were manually added) and visualized with Cytoscape (Orchard et al. 2014; Shannon et al. 2003). Both direct interactions and indirect associations of CD2AP are shown.
Function The presence of binding domains allows CD2AP to control the assembly of multiprotein complexes and to transmit signals involved in different biological processes. The protein was first identified as p130-Cas interactor (and named CMS as "Cas ligand with Multiple SH3") and its colocalization with p130-Cas and F-actin strongly suggested for a function in the regulation of the actin cytoskeleton as an adaptor protein (Kirsch et al. 1999). This role was largely confirmed by subsequent observations: in normal cells, monomeric actin (G actin) polymerises in filaments (F actin) that bind to CD2AP (Gaidos et al. 2007); in podocytes the absence of CD2AP causes a dramatic defect due to the loss of their specialised actin-rich foot processes that operate the filtration in kidney (Shih et al 1999 ; Gaidos et al. 2007). It was further shown that to guarantee stability to the actin polymer, its barbed ends are in complex with the actin-capping protein CP that avoid the addiction and the loss of monomers. In the presence of CD2AP, CP is prevented to bind actin filaments barbed end, and actin filaments can be extended or shortened (Bruck et al. 2006). Notably, CD2AP is required to recruit CP to the cell periphery during lamellipodia formation (Zhao et al. 2013) and to regulate actin accumulation at the adherens junctions (Tang and Brieher 2013). An independent work identified mouse CD2AP as CD2 receptor clustering activator in the specialized junctions between T cells and antigen-presenting cells (Dustin et al. 1998). This interaction also connects surface receptors to the actin cytoscheleton. A similar model was proposed in Drosophila, where Cindr, the CD2AP homolog, was shown to link cell-cell adhesion junctions with actin cytoscheleton by binding to E-Cadherin and IgCAM Roughest (Johnson et al. 2008; Johnson et al. 2012). It was also observed that upon EGF treatment CBL associates to CD2AP that recruits it to membrane ruffles where they both colocalize (Kirsch et al. 2001; Lynch et al. 2003), linking endocytosis to actin polymerization. RAC1 was found in membrane ruffles in complex with CTTN (cortactin) and CD2AP (Van Dujin et al. 2011). Recently it was suggested that the adaptor protein may anchor a fraction of the 72R variant of the TP53 protein in the cytosol, connecting it with membrane receptors and actin cytoscheleton (Panni et al. 2015). All these observations suggest for a role of CD2AP in regulating membrane proteins and specialized cell junctions and to connect them with actin cytoscheleton dynamics.
 
  The sequence alignment of the two homolog human proteins CD2AP and Cin85. The SH3 domains are highlighted in yellow and the proline-rich in green. Pink letters indicate the CP binding motif and the Coiled-Coil region. AP2 binding motifs are underlined and positions annotated as potential missense or nonsense mutations in Cosmic database (Forbes et al. 2017) are represented by red letters.
Homology CD2AP is a member of the Cin85/CMS family of adaptor proteins which comprises two paralogs: CD2AP (CMS) and Cin85 (Figure 5) . They are conserved among mammalian species, but not in C. elegans and yeast. The D. melanogaster homolog, Cindr, only share 30% of homology with CD2AP (Blast Alignment tool https://blast.ncbi.nlm.nih.gov/Blast.cgi).

Mutations

Note 101 missense substitutions plus 8 nonsense substitutions mapping in the coding region of CD2AP gene have been annotated in the Cosmic Database (Forbes et al. 2017) from tumorigenic tissues analysis (positions involved are shown as red letters in Figure 5) , however none of them has been clearly associated with the tumorigenic tissue analysed. Mutation R612STOP was also found in one patient affected from focal segmental glomerulosclerosis (FSGS, see below) and it was shown that the mutation impairs gene expression (Lowik et al. 2007). 32 synonymous mutations have also been reported in Cosmic (not shown in the figure).
Two mutations of the splicing acceptor site of exon seven, that result in a lower expression of the gene, have been reported from FSGS patients (Kim et al. 2003).

Implicated in

Note CD2AP gene is clearly implicated in Focal Segmental Glomerulosclerosis, and its polymorphisms have been associated with Alzheimer Disease. Instead, although it was shown to interact with many proteins involved in signal transduction and with p53, its involvement in the development of cancer is not well documented. According to data provided by Human Protein Atlas and obtained with antibodies against CD2AP, the protein is strongly expressed in pancreatic, gastric, colorectal, prostate, breast, ovarian and urothelial cancers and in it is used as a prognostic marker in pancreatic cancer and urothelial cancer. It is a marker for plasmacytoid dendritic cell neoplasm too (see below).
It has been proposed as a promising target for ErbB2 overexpressing tumors since it participates in the inhibition of activated ErbB2 (Mineghishi et al. 2013).
  
Entity Focal Segmental Glomerulosclerosis
Note Mice CD2AP-/- die by 6-7 weeks of age for severe kidney pathology and proteinuria. In particular they showed glomerular injury with loss of podocyte foot processes and slit diaphragm integrity and with extracellular deposits of fibronectin and collagen (Shih et al. 1999). At molecular level, CD2AP immunoprecipitates with nephrin, the major component of the slit diaphragm (Shih et al. 1999 ; Shih et al. 2001), suggesting that the pathology arises from a deregulation of actin polymerisation in foot processes and loss of connection between nephrin and the actin cytoscheleton. Mice with CD2AP haploinsufficiency develop glomerular defects similar to the human focal segmental glomerulosclerosis disease, and in human patients mutations in CD2AP coding sequence or in the splicing regulatory regions were associated with the pathology (Kim et al. 2003; Lowik et al. 2007; Chen & Liapis, 2015)
Disease Focal Segmental Glomerulosclerosis (FSGS) is a progressive glomerular disease characterized by localised sclerotic lesions (only some of the glomeruli are involved and only a part of them is affected) and podocyte loss. Glomerulus is a specialized apparatus to filter blood in kidney and the filtration barrier is constituted by endothelial cells, glomerular basement membrane and foot processes called podocytes (Shih et al. 1999). In FSGS patients, non functional podocytes are detached from the glomerular basement membrane which results in severe nephrosis with proteinuria and glomerulosclerosis (Nagata et al, 2017). Extracellular deposits of collagens and other fibrous proteins are also observed in affected glomeruli. 30% of all nephrotic syndromes in adults are due to FSGS with elevated costs to health care (Nagata et al. 2017).
  
  
Entity Alzheimer Disease
Note CD2AP polymorphisms were found associated with late onset Alzheimer's disease (LOAD, see below) in two genome-wide association studies (Hollingworth et al. 2011; Naj et al. 2011). In particular, SNPs rs9296559 and rs9349407 were found associated with increased LOAD risk. Very little is known about how the protein may affect the AD risk and what function it exerts in brain. Its role in vescicular transport to the lysosome and in the formation of synapses may be relevant to its involvment (Karch & Goate, 2015). It was recently shown that CD2AP knock-down mice have a compromised blood-brain barrier with increased permeability, and the function of CD2AP in maintaining blood barrier integrity was proposed to be related with the higher predisposition to the disease (Cochran et al. 2015). It was also shown that the deletion of CD2AP determine a decrease in Aβ levels (Liao et al. 2015).
Disease The Alzheimer's Disease (AD) is a complex multifactorial neuronal disease characterized by extensive neuronal loss due to extracellular deposition of beta amyloid plaques (Aβ) and intracellular development of neurofibrillary tangles (NTF). AD is classified in late-onset AD (LOAD), that occurs in elderly people and is one of the most common cause of dementia, and early-onset AD (EOAD) when the disease occurs in young people (Rosenthal and Kamboh et al. 2014).
  
  
Entity NAME Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Note CD2AP has been proposed as a specific marker to diagnostic BPDCN among other hematological neoplastic disorders because it is expressed at high level in both normal and transformed pDC cells. The molecular diagnosis of myeloproliferative disorders is based on markers such as CD4 or CD56 that are expressed in different cell types. Instead CD2AP, unless it was originally cloned in T cells, was shown to strongly react to specific antibodies only in pDC cells, suggesting that it may represent an interesting marker for pDC derived malignancies (Marafioti et al. 2008; Rizvi et al. 2012).
Disease Blastic Plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy involving plasmacytoid dendritic cells (pDC), that was classified in 2008 under acute myeloid leukemia (Riaz et al. 2014). It represents only 0.44% of the hematological malignancies however patients have poor outcomes, with median survival ranging from 12 to 16 months. Most patients present cutaneous lesions, while bone marrow, peripheral blood and lymph nodes are also involved (Riaz et al. 2014).
  

Bibliography

Accessory protein recruitment motifs in clathrin-mediated endocytosis.
Brett TJ, Traub LM, Fremont DH (2002)
Structure 2002 10: 797-809
PMID 12057195
 
Identification of a novel inhibitory actin-capping protein binding motif in CD2-associated protein. The Journal of biological chemistry
Bruck S, Huber TB, Ingham RJ, Kim K, Niederstrasser H, Allen PM, Pawson T, Cooper JA, Shaw AS
The Journal of Biological Chemistry 2006 281: 19196-19203
PMID 16707503
 
Focal segmental glomerulosclerosis: molecular genetics and targeted therapies
Chen YM, Liapis H
BMC Nephrology 2015 16: 101
PMID 26156092
 
The Alzheimer's disease risk factor CD2AP maintains blood-brain barrier integrity.
Cochran JN, Rush T, Buckingham SC, Roberson ED
Human Molecular Genetics 2015 24: 6667-6674
PMID 26358779
 
CIN85/CMS family of adaptor molecules
Dikic I
FEBS letters 2002 529: 110-115
PMID 12354621
 
A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts
Dustin ML, Olszowy MW, Holdorf AD, Li J, Bromley S, Desai N, Widder P, Rosenberger F, van der Merwe PA, Allen PM, Shaw AS
Cell 1998 94: 667-677
PMID 9741631
 
COSMIC: Somatic cancer genetics at high-resolution.
Forbes SA, Beare D, Boutselakis H, Bamford S, Bindal N, Tate J, Cole CG, Ward S, Dawson E, Ponting L, Stefancsik R, Harsha B, Kok CY, Jia M, Jubb H, Sondka Z, Thompson S, De T, Campbell PJ
Nucleic Acids Research 2017 45: D777-D78
PMID 27899578
 
Structure and function analysis of the CMS/CIN85 protein family identifies actin-bundling properties and heterotypic-complex formation
Gaidos G, Soni S, Oswald DJ, Toselli PA, Kirsch KH
Journal of Cell Science (2007) 120: 2366-2377
PMID 17606992
 
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.
Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC et al.
Nature Genetics 2011 43: 429-435
PMID 21460840
 
Interactions between Drosophila IgCAM adhesion receptors and cindr, the Cd2ap/Cin85 ortholog
Johnson RI, Bao S, Cagan RL
Developmental Dynamics 2012 241: 1933-1943
PMID 23027549
 
Alzheimer's disease risk genes and mechanisms of disease pathogenesis.
Karch CM, Goate AM
Biological Psychiatry 2015 77: 43-51
PMID 24951455
 
CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility
Kim JM, Wu H, Green G, Winkler CA, Kopp JB, Miner JH, Unanue ER, Shaw AS
Science 2003 300: 1298-1300
PMID 12764198
 
The adapter type protein CMS/CD2AP binds to the proto-oncogenic protein c-Cbl through a tyrosine phosphorylation-regulated Src homology 3 domain interaction.
Kirsch KH, Georgescu MM, Shishido T, Langdon WY, Birge RB, Hanafusa H
The Journal of Biological Chemistry 2001 276: 4957-4963
PMID 11067845
 
CD2-associated protein directly interacts with the actin cytoskeleton.
Lehtonen S, Zhao F, Lehtonen E
American journal of physiology Renal physiology 2002 283: F734-743
PMID 12217865
 
Effects of CD2-associated protein deficiency on amyloid-beta in neuroblastoma cells and in an APP transgenic mouse model.
Liao F, Jiang H, Srivatsan S, Xiao Q, Lefton KB, Yamada K, Mahan TE, Lee JM, Shaw AS, Holtzman DM
Molecular Neurodegeneration 2015 10:12
PMID 25887956
 
Focal segmental glomerulosclerosis in a patient homozygous for a CD2AP mutation.
Lowik MM, Groenen PJ, Pronk I, Lilien MR, Goldschmeding R, Dijkman HB, Levtchenko EN, Monnens LA, van den Heuvel LP
Kidney International 2007 72: 1198-1203
PMID 17713465
 
A Cortactin-CD2-associated protein (CD2AP) complex provides a novel link between epidermal growth factor receptor endocytosis and the actin cytoskeleton.
Lynch DK, Winata SC, Lyons RJ, Hughes WE, Lehrbach GM, Wasinger V, Corthals G, Cordwell S, Daly RJ
The Journal of Biological Chemistry 2003 278: 21805-21813
PMID 12672817
 
Novel markers of normal and neoplastic human plasmacytoid dendritic cells.
Marafioti T, Paterson JC, Ballabio E, Reichard KK, Tedoldi S, Hollowood K, Dictor M, Hansmann ML, Pileri SA, Dyer MJ, Sozzani S, Dikic I, Shaw AS, Petrella T, Stein H, Isaacson PG, Facchetti F, Mason DY
Blood 2008 111: 3778-3792
PMID 18218851
 
Adaptor protein complex of FRS2? and CIN85/CD2AP provides a novel mechanism for ErbB2/HER2 protein downregulation.
Minegishi Y, Shibagaki Y, Mizutani A, Fujita K, Tezuka T, Kinoshita M, Kuroda M, Hattori S, Gotoh N.
Cancer Sci. 2013 104(3):345-52
PMID 23279575
 
Atypical polyproline recognition by the CMS N-terminal Src homology 3 domain.
Moncalian G, Cardenes N, Deribe YL, Spinola-Amilibia M, Dikic I, Bravo J
The Journal of Biological Chemistry 2006 281: 38845-38853
PMID 17020880
 
Focal segmental glomerulosclerosis; why does it occur segmentally?
Nagata M, Kobayashi N, Hara S
Pflugers Archiv : European Journal of Physiology 2017 469: 983-988
PMID 28664408
 
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J et al.
Nature Genetics 2011 43: 436-441
PMID 21460841
 
The MIntAct project--IntAct as a common curation platform for 11 molecular interaction databases
Orchard S, Ammari M, Aranda B, Breuza L, Briganti L, Broackes-Carter F et al.
Nucleic Acids Research 2014 42: D358-363
PMID 24234451
 
The adapter protein CD2AP binds to p53 protein in the cytoplasm and can discriminate its polymorphic variants P72R.
Panni S, Salvioli S, Santonico E, Langone F, Storino F, Altilia S, Franceschi C, Cesareni G, Castagnoli L.
Journal of Biochemistry 2015 157: 101-111
PMID 25261582
 
Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.
Riaz W, Zhang L, Horna P, Sokol L
Cancer Control 2014 21: 279-289
PMID 25310209
 
Expression of the CD2AP adaptor molecule in normal, reactive and neoplastic human tissue.
Rizvi H, Paterson JC, Tedoldi S, Ramsay A, Calaminici M, Natkunam Y, Lonardi S, Tan SY, Campbell L, Hansmann ML, Jones D, Dikic I, Shaw AS, Pileri SA, Stein H, Mason DY, Facchetti F, Marafioti T
Pathologica 2012 104: 56-64
PMID 22953501
 
Late-Onset Alzheimer's Disease Genes and the Potentially Implicated Pathways
Rosenthal SL and Kamboh MI
Curr. Genet. Med. Rep. 2014 2:85-101
PMID 24829845
 
Cytoscape: a software environment for integrated models of biomolecular interaction networks
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T
Genome Research 2003 13:2498-2504
PMID 14597658
 
CD2AP localizes to the slit diaphragm and binds to nephrin via a novel C-terminal domain.
Shih NY, Li J, Cotran R, Mundel P, Miner JH, Shaw AS
The American Journal of Pathology 2001 159: 2303-2308
PMID 11733379
 
Two distinct mechanisms for actin capping protein regulation-steric and allosteric inhibition.
Takeda S, Minakata S, Koike R, Kawahata I, Narita A, Kitazawa M, Ota M, Yamakuni T, Maeda Y, Nitanai Y
PLoS Biology 2010 8: e1000416
PMID 20625546
 
FSGS3/CD2AP is a barbed-end capping protein that stabilizes actin and strengthens adherens junctions
Tang VW, Brieher WM
The Journal of Cell Biology 2013 203: 815-833
PMID 24322428
 
Solution structure of the second SH3 domain of human CMS and a newly identified binding site at the C-terminus of c-Cbl.
Yao B, Zhang J, Dai H, Sun J, Jiao Y, Tang Y, Wu J, Shi Y
Biochimica et Biophysica Acta 2007 1774: 35-43
PMID 17188587
 
Nephrin dissociates from actin, and its expression is reduced in early experimental membranous nephropathy.
Yuan H, Takeuchi E, Taylor GA, McLaughlin M, Brown D, Salant DJ
Journal of the American Society of Nephrology 2002 13: 946-956
PMID 11912254
 
CD2AP links cortactin and capping protein at the cell periphery to facilitate formation of lamellipodia.
Zhao J, Bruck S, Cemerski S, Zhang L, Butler B, Dani A, Cooper JA, Shaw AS
Molecular and Cellular Biology 2013 33: 38-47
PMID 23090967
 
Rac1 recruits the adapter protein CMS/CD2AP to cell-cell contacts.
van Duijn TJ, Anthony EC, Hensbergen PJ, Deelder AM, Hordijk PL
The Journal of Biological Chemistry 2010 285: 20137-20146
PMID 20404345
 

Citation

This paper should be referenced as such :
Panni S
CD2AP (CD2 associated protein);
Atlas Genet Cytogenet Oncol Haematol. in press
On line version : http://AtlasGeneticsOncology.org/Genes/CD2APID54896ch6p12.html


Other Solid tumors implicated (Data extracted from papers in the Atlas) [ 6 ]
  t(6;6)(p12;p12) PTCHD4/CD2AP
t(6;6)(p12;p21) CD2AP/USP49
t(6;6)(p12;p21) CD2AP/NFKBIE
t(6;6)(p12;p21) CD2AP/SUPT3H
t(6;6)(p12;p22) ZNF184/CD2AP
t(6;6)(p12;p24) CD2AP/BLOC1S5


External links

Nomenclature
HGNC (Hugo)CD2AP   14258
Cards
AtlasCD2APID54896ch6p12
Entrez_Gene (NCBI)CD2AP  23607  CD2 associated protein
AliasesCMS
GeneCards (Weizmann)CD2AP
Ensembl hg19 (Hinxton)ENSG00000198087 [Gene_View]
Ensembl hg38 (Hinxton)ENSG00000198087 [Gene_View]  chr6:47477789-47627260 [Contig_View]  CD2AP [Vega]
ICGC DataPortalENSG00000198087
TCGA cBioPortalCD2AP
AceView (NCBI)CD2AP
Genatlas (Paris)CD2AP
WikiGenes23607
SOURCE (Princeton)CD2AP
Genetics Home Reference (NIH)CD2AP
Genomic and cartography
GoldenPath hg38 (UCSC)CD2AP  -     chr6:47477789-47627260 +  6p12.3   [Description]    (hg38-Dec_2013)
GoldenPath hg19 (UCSC)CD2AP  -     6p12.3   [Description]    (hg19-Feb_2009)
EnsemblCD2AP - 6p12.3 [CytoView hg19]  CD2AP - 6p12.3 [CytoView hg38]
Mapping of homologs : NCBICD2AP [Mapview hg19]  CD2AP [Mapview hg38]
OMIM604241   607832   
Gene and transcription
Genbank (Entrez)AF146277 AF164377 AJ420469 AL050105 BC069444
RefSeq transcript (Entrez)NM_012120
RefSeq genomic (Entrez)
Consensus coding sequences : CCDS (NCBI)CD2AP
Cluster EST : UnigeneHs.485518 [ NCBI ]
CGAP (NCI)Hs.485518
Alternative Splicing GalleryENSG00000198087
Gene ExpressionCD2AP [ NCBI-GEO ]   CD2AP [ EBI - ARRAY_EXPRESS ]   CD2AP [ SEEK ]   CD2AP [ MEM ]
Gene Expression Viewer (FireBrowse)CD2AP [ Firebrowse - Broad ]
SOURCE (Princeton)Expression in : [Datasets]   [Normal Tissue Atlas]  [carcinoma Classsification]  [NCI60]
GenevestigatorExpression in : [tissues]  [cell-lines]  [cancer]  [perturbations]  
BioGPS (Tissue expression)23607
GTEX Portal (Tissue expression)CD2AP
Human Protein AtlasENSG00000198087-CD2AP [pathology]   [cell]   [tissue]
Protein : pattern, domain, 3D structure
UniProt/SwissProtQ9Y5K6   [function]  [subcellular_location]  [family_and_domains]  [pathology_and_biotech]  [ptm_processing]  [expression]  [interaction]
NextProtQ9Y5K6  [Sequence]  [Exons]  [Medical]  [Publications]
With graphics : InterProQ9Y5K6
Splice isoforms : SwissVarQ9Y5K6
PhosPhoSitePlusQ9Y5K6
Domaine pattern : Prosite (Expaxy)SH3 (PS50002)   
Domains : Interpro (EBI)CD2AP    SH3_domain   
Domain families : Pfam (Sanger)SH3_1 (PF00018)    SH3_9 (PF14604)   
Domain families : Pfam (NCBI)pfam00018    pfam14604   
Domain families : Smart (EMBL)SH3 (SM00326)  
Conserved Domain (NCBI)CD2AP
DMDM Disease mutations23607
Blocks (Seattle)CD2AP
PDB (SRS)2FEI    2J6F    2J6K    2J6O    2J7I    3AA6    3LK4    3U23    4WCI    4X1V   
PDB (PDBSum)2FEI    2J6F    2J6K    2J6O    2J7I    3AA6    3LK4    3U23    4WCI    4X1V   
PDB (IMB)2FEI    2J6F    2J6K    2J6O    2J7I    3AA6    3LK4    3U23    4WCI    4X1V   
PDB (RSDB)2FEI    2J6F    2J6K    2J6O    2J7I    3AA6    3LK4    3U23    4WCI    4X1V   
Structural Biology KnowledgeBase2FEI    2J6F    2J6K    2J6O    2J7I    3AA6    3LK4    3U23    4WCI    4X1V   
SCOP (Structural Classification of Proteins)2FEI    2J6F    2J6K    2J6O    2J7I    3AA6    3LK4    3U23    4WCI    4X1V   
CATH (Classification of proteins structures)2FEI    2J6F    2J6K    2J6O    2J7I    3AA6    3LK4    3U23    4WCI    4X1V   
SuperfamilyQ9Y5K6
Human Protein Atlas [tissue]ENSG00000198087-CD2AP [tissue]
Peptide AtlasQ9Y5K6
HPRD05026
IPIIPI00412771   
Protein Interaction databases
DIP (DOE-UCLA)Q9Y5K6
IntAct (EBI)Q9Y5K6
FunCoupENSG00000198087
BioGRIDCD2AP
STRING (EMBL)CD2AP
ZODIACCD2AP
Ontologies - Pathways
QuickGOQ9Y5K6
Ontology : AmiGOruffle  vascular endothelial growth factor receptor binding  structural constituent of cytoskeleton  protein binding  cytoplasm  plasma membrane  cell-cell junction  protein complex assembly  substrate-dependent cell migration, cell extension  actin filament organization  cell cycle  signal transduction  beta-catenin binding  protein C-terminus binding  actin cytoskeleton  vesicle organization  SH3 domain binding  endocytic vesicle  filamentous actin  protein complex binding  negative regulation of transforming growth factor beta1 production  proteasome-mediated ubiquitin-dependent protein catabolic process  cadherin binding  regulation of receptor-mediated endocytosis  perinuclear region of cytoplasm  negative regulation of small GTPase mediated signal transduction  cell division  extracellular exosome  cell-cell adhesion  positive regulation of protein localization to nucleus  regulation of actin cytoskeleton reorganization  
Ontology : EGO-EBIruffle  vascular endothelial growth factor receptor binding  structural constituent of cytoskeleton  protein binding  cytoplasm  plasma membrane  cell-cell junction  protein complex assembly  substrate-dependent cell migration, cell extension  actin filament organization  cell cycle  signal transduction  beta-catenin binding  protein C-terminus binding  actin cytoskeleton  vesicle organization  SH3 domain binding  endocytic vesicle  filamentous actin  protein complex binding  negative regulation of transforming growth factor beta1 production  proteasome-mediated ubiquitin-dependent protein catabolic process  cadherin binding  regulation of receptor-mediated endocytosis  perinuclear region of cytoplasm  negative regulation of small GTPase mediated signal transduction  cell division  extracellular exosome  cell-cell adhesion  positive regulation of protein localization to nucleus  regulation of actin cytoskeleton reorganization  
REACTOMEQ9Y5K6 [protein]
REACTOME PathwaysR-HSA-373753 [pathway]   
NDEx NetworkCD2AP
Atlas of Cancer Signalling NetworkCD2AP
Wikipedia pathwaysCD2AP
Orthology - Evolution
OrthoDB23607
GeneTree (enSembl)ENSG00000198087
Phylogenetic Trees/Animal Genes : TreeFamCD2AP
HOVERGENQ9Y5K6
HOGENOMQ9Y5K6
Homologs : HomoloGeneCD2AP
Homology/Alignments : Family Browser (UCSC)CD2AP
Gene fusions - Rearrangements
Fusion : MitelmanCD2AP/BLOC1S5 [6p12.3/6p24.3]  
Fusion : MitelmanCD2AP/NFKBIE [6p12.3/6p21.1]  [t(6;6)(p12;p21)]  
Fusion : MitelmanCD2AP/SUPT3H [6p12.3/6p21.1]  [t(6;6)(p12;p21)]  
Fusion : MitelmanCD2AP/USP49 [6p12.3/6p21.1]  [t(6;6)(p12;p21)]  
Fusion : MitelmanPTCHD4/CD2AP [6p12.3/6p12.3]  [t(6;6)(p12;p12)]  
Fusion : MitelmanZNF184/CD2AP [6p22.1/6p12.3]  [t(6;6)(p12;p22)]  
Fusion: TCGA_MDACCC6orf138 CD2AP 6p12.3 KIRC
Fusion: TCGA_MDACCCD2AP 6p12.3 MUTED BRCA
Fusion: TCGA_MDACCCD2AP 6p12.3 NFKBIE 6p21.1 LUAD
Fusion: TCGA_MDACCCD2AP 6p12.3 SUPT3H 6p21.1 LUAD
Fusion: TCGA_MDACCCD2AP 6p12.3 USP49 6p21.1 KIRC
Fusion: TCGA_MDACCZNF184 6p22.1 CD2AP 6p12.3 BRCA
Fusion PortalC6orf138 CD2AP 6p12.3 KIRC
Fusion PortalCD2AP 6p12.3 MUTED BRCA
Fusion PortalCD2AP 6p12.3 NFKBIE 6p21.1 LUAD
Fusion PortalCD2AP 6p12.3 SUPT3H 6p21.1 LUAD
Fusion PortalCD2AP 6p12.3 USP49 6p21.1 KIRC
Fusion PortalZNF184 6p22.1 CD2AP 6p12.3 BRCA
Fusion : QuiverCD2AP
Polymorphisms : SNP and Copy number variants
NCBI Variation ViewerCD2AP [hg38]
dbSNP Single Nucleotide Polymorphism (NCBI)CD2AP
dbVarCD2AP
ClinVarCD2AP
1000_GenomesCD2AP 
Exome Variant ServerCD2AP
ExAC (Exome Aggregation Consortium)ENSG00000198087
GNOMAD BrowserENSG00000198087
Genetic variants : HAPMAP23607
Genomic Variants (DGV)CD2AP [DGVbeta]
DECIPHERCD2AP [patients]   [syndromes]   [variants]   [genes]  
CONAN: Copy Number AnalysisCD2AP 
Mutations
ICGC Data PortalCD2AP 
TCGA Data PortalCD2AP 
Broad Tumor PortalCD2AP
OASIS PortalCD2AP [ Somatic mutations - Copy number]
Somatic Mutations in Cancer : COSMICCD2AP  [overview]  [genome browser]  [tissue]  [distribution]  
Mutations and Diseases : HGMDCD2AP
LOVD (Leiden Open Variation Database)Whole genome datasets
LOVD (Leiden Open Variation Database)LOVD - Leiden Open Variation Database
LOVD (Leiden Open Variation Database)LOVD 3.0 shared installation
BioMutasearch CD2AP
DgiDB (Drug Gene Interaction Database)CD2AP
DoCM (Curated mutations)CD2AP (select the gene name)
CIViC (Clinical Interpretations of Variants in Cancer)CD2AP (select a term)
intoGenCD2AP
NCG5 (London)CD2AP
Cancer3DCD2AP(select the gene name)
Impact of mutations[PolyPhen2] [SIFT Human Coding SNP] [Buck Institute : MutDB] [Mutation Assessor] [Mutanalyser]
Diseases
OMIM604241    607832   
Orphanet12195    12191   
DisGeNETCD2AP
MedgenCD2AP
Genetic Testing Registry CD2AP
NextProtQ9Y5K6 [Medical]
TSGene23607
GENETestsCD2AP
Target ValidationCD2AP
Huge Navigator CD2AP [HugePedia]
snp3D : Map Gene to Disease23607
BioCentury BCIQCD2AP
ClinGenCD2AP
Clinical trials, drugs, therapy
Chemical/Protein Interactions : CTD23607
Chemical/Pharm GKB GenePA26208
Clinical trialCD2AP
Miscellaneous
canSAR (ICR)CD2AP (select the gene name)
Probes
Litterature
PubMed105 Pubmed reference(s) in Entrez
GeneRIFsGene References Into Functions (Entrez)
CoreMineCD2AP
EVEXCD2AP
GoPubMedCD2AP
iHOPCD2AP
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Wed Feb 28 13:49:50 CET 2018

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.